— Know what they know.
Not Investment Advice

600613.SS SHH

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
1W: -13.2% 1M: -26.6% 3M: +74.3% YTD: +25.8% 1Y: +17.5% 3Y: +27.2% 5Y: +67.1%
¥8.19 ($1.22)
+0.08 (+0.99%)
 
SHH · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 45 · ¥3.9B mcap · 236M float · 18.10% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap¥3.9B ($585.4M)
52W Range4.33-12.77
Volume59,711,436
Avg Volume42,693,728
Beta0.41
Dividend¥0.07
Analyst Ratings
No analyst coverage
Company Info
CEOFeng Bin
Employees1,196
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date1992-08-20
Websitegzsq.com
Changfa Tower
Shanghai, SH 200003
CN
86 21 5375 0009
About Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., through its various subsidiaries, functions as a pharmaceutical manufacturing holding and investment entity within China. The company's operations encompass the research, development, and production of a broad spectrum of medications. Its therapeutic focus includes pharmaceuticals for oncology, cardiovascular and cerebrovascular conditions, respiratory issues (such as colds and coughs), pediatric care, and antifungal treatments, alongside general health tonics. The firm's product portfolio features both prescription-only drugs and readily available over-the-counter (OTC) remedies. Established in Shanghai, China, in 1992, the company continues to operate from this location.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms